David L. Swerdlow

Harvard University - Center for Communicable Disease Dynamics

Boston, MA

United States

  • Harvard University - Center for Communicable Disease Dynamics

SCHOLARLY PAPERS

5

DOWNLOADS
Rank 43,015

SSRN RANKINGS

Top 43,015

in Total Papers Downloads

2,525

TOTAL CITATIONS

9

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Nationwide Vaccination Campaign with BNT162b2 in Israel Demonstrates High Vaccine Effectiveness and Marked Declines in Incidence of SARS-CoV-2 Infections and COVID-19 Cases, Hospitalizations, and Deaths

Number of pages: 24 Posted: 24 Mar 2021
Eric J. Haas, Frederick J. Angulo, John M. McLaughlin, Emilia Anis, Shepherd R. Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jodar, Yeheskel Levy and Sharon Alroy-Preis
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Pfizer, Inc., Ministry of Health (Israel) - Public Health Services, Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Ministry of Health (Israel) - Information Technology Department, Ministry of Health (Israel) - Information Technology Department, Pfizer Pharmaceuticals Israel Ltd, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 1,670 (23,449)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, vaccine effectiveness, prevention, mRNA vaccines, pandemic, observational study, epidemiology

2.

Infections, Hospitalizations, and Deaths Averted Via Direct Effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Vaccination Campaign, Israel

Number of pages: 25 Posted: 13 May 2021
Eric J. Haas, John M. McLaughlin, Farid Khan, Frederick J. Angulo, Emilia Anis, Emilia Anis, Marc Lipsitch, Shepherd R. Singer, Gabriel Mircus, Nati Brooks, Meir Smaja, Kaijie Pan, Jo Southern, David L. Swerdlow, Luis Jodar, Yeheskel Levy and Sharon Alroy-Preis
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Yale UniversityMinistry of Health (Israel) - Public Health Services, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Ministry of Health (Israel) - Public Health Services, Pfizer Pharmaceuticals Israel Ltd, Ministry of Health (Israel) - Information Technology Department, Ministry of Health (Israel) - Information Technology Department, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 472 (131,969)
Citation 4

Abstract:

Loading...

COVID-19, SARS-CoV-2, cases averted, impact, hospitalizations, deaths, Israel, model, public health, pandemic

3.

Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel

Number of pages: 29 Posted: 13 Aug 2021
Shepherd R. Singer, Frederick J. Angulo, David L. Swerdlow, John M. McLaughlin, Itay Hazan, Netanel Ginish, Emilia Anis, Emilia Anis, Ella Mendelson, Orna Mor, Neta S. Zuckerman, Oran Erster, Jo Southern, Kaijie Pan, Gabriel Mircus, Marc Lipsitch, Eric J. Haas, Luis Jodar, Yeheskel Levy and Sharon Alroy-Preis
Ministry of Health (Israel) - Public Health Services, Pfizer, Inc., Harvard University - Center for Communicable Disease Dynamics, Pfizer, Inc., Ministry of Health (Israel), Israel Ministry of Health, Yale UniversityMinistry of Health (Israel) - Public Health Services, Sheba Medical Center - Central Virology Laboratory, Sheba Medical Center - Central Virology Laboratory, Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc., Pfizer Pharmaceuticals Israel Ltd, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Ministry of Health (Israel) - Public Health Services, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Ministry of Health (Israel) and Ministry of Health (Israel) - Department of Maternal and Child Health
Downloads 200 (327,989)
Citation 1

Abstract:

Loading...

4.

Methods for Early Characterization of the Severity and Dynamics of SARS-CoV-2 Variants in South Africa

Number of pages: 20 Posted: 07 Apr 2022
Emily Reichert, Beau Schaeffer, Shae Gantt, Eva Rumpler, Nevashan Govender, Richard Welch, Andronica M. Shonhiwa, Chidozie Declan Iwu, Teresa Mashudu Lamola, Itumeleng Moema-Matiea, Darren Muganhiri, William P. Hanage, Mauricio Santillana, Waasila Jassat, Cheryl Cohen and David L. Swerdlow
Harvard University - Center for Communicable Disease Dynamics, Harvard University - Center for Communicable Disease Dynamics, Harvard University - Center for Communicable Disease Dynamics, Harvard University - Center for Communicable Disease Dynamics, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, National Institute For Communicable Diseases Of South Africa - Division of Public Health Surveillance and Response, Harvard T.H. Chan School of Public Health - Center for Communicable Disease Dynamics, Harvard University - Center for Communicable Disease Dynamics, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis and Harvard University - Center for Communicable Disease Dynamics
Downloads 98 (586,302)

Abstract:

Loading...

COVID-19, hospital admissions, severity, Omicron SARS-CoV-2 variant, South Africa, variants of concern

5.

County-Level Vaccination Coverage and Rates of COVID-19 Cases and Deaths in the United States

Number of pages: 30 Posted: 20 Aug 2021
John M. McLaughlin, Farid Khan, Sarah Pugh, David L. Swerdlow and Luis Jodar
Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Harvard University - Center for Communicable Disease Dynamics and Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs
Downloads 85 (640,870)
Citation 3

Abstract:

Loading...